Physician profile
Jerry Hensel
NPI 1851488126
$1,900.34
in general payments reported to CMS, 2019-2025
12 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.49 · 2020: $1,276 · 2021: $42.34 · 2022: $48.46 · 2023: $180 · 2024: $154 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $1,275.67 | 2020 | |
| Sun Pharmaceutical Industries INC. | $149.39 | 2024-2025 | |
| Sight Sciences, INC. | $131.04 | 2023 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $77.55 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $63.43 | 2022-2024 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $55.11 | 2019-2025 | Rocklatan, Clareon |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.04 | 2019-2021 | |
| Abbvie INC. | $27.98 | 2022 | |
| Allergan, INC. | $24.04 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $21.45 | 2023 | |
| Shire North American Group INC | $19.40 | 2019 | |
| Biotissue Holdings INC. | $13.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Hensel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.